An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
NACompletedINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Pentoxifylline
Trial Locations (1)
02445
CRI of New England, Brookline
All Listed Sponsors
lead
Community Research Initiative of New England
OTHER
NCT00002091 - An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent | Biotech Hunter | Biotech Hunter